We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

65 hedge funds and large institutions have $270M invested in Syneron Medical Ltd in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

7% more funds holding

Funds holding: 61 → 65 (+4)

3% less capital invested

Capital invested by funds: $278M → $270M (-$8.38M)

37% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 19

Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
12
Reduced
19
Closed
7
Calls
$681K
Puts
–
Net Calls
+$681K
Net Calls Change
+$679K

Top Buyers

Rank Fund Capital Flow
1
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
+$8.04M
2
BIP
Brandes Investment Partners
California
+$2.26M
3
Ameriprise
Ameriprise
Minnesota
+$1.64M
4
IHM
Iguana Healthcare Management
New York
+$1.22M
5
SC
Sophrosyne Capital
New York
+$725K

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$10.2M
2
Norges Bank
Norges Bank
Norway
-$2.33M
3
PAIM
Punch & Associates Investment Management
Minnesota
-$647K
4
Citadel Advisors
Citadel Advisors
Florida
-$634K
5
FCM
Frontier Capital Management
Massachusetts
-$619K
Name Holding Trade Value Shares
Change 		Change in
Stake
DC
26
Davenport & Co
Virginia
$1.18M +$134K +13,200 +13%
PIM
27
Profit Investment Management
Maryland
$1.05M -$193K -18,930 -15%
TA
28
Teton Advisors
New York
$1.01M – – –
PIM
29
Platinum Investment Management
Australia
$945K – – –
DCM
30
DAFNA Capital Management
California
$911K – – –
Bank of New York Mellon
31
Bank of New York Mellon
New York
$758K -$237K -23,250 -24%
SC
32
Sophrosyne Capital
New York
$713K +$725K +71,300 New
Two Sigma Investments
33
Two Sigma Investments
New York
$666K -$120K -11,839 -15%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$636K -$32K -3,145 -5%
Nomura Holdings
35
Nomura Holdings
Japan
$604K +$224K +22,047 +58%
Point72 Asset Management
36
Point72 Asset Management
Connecticut
$601K +$610K +60,000 New
Two Sigma Advisers
37
Two Sigma Advisers
New York
$578K +$12.2K +1,200 +2%
MC
38
Moors & Cabot
Massachusetts
$460K +$12.7K +1,250 +3%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$347K – – –
GI
40
GAMCO Investors
Connecticut
$240K – – –
IAM
41
Iridian Asset Management
Connecticut
$211K +$4.48K +440 +2%
NCMW
42
Northern Capital Management (Wisconsin)
Wisconsin
$209K +$212K +20,825 New
BG
43
BlackRock Group
United Kingdom
$166K – – –
Invesco
44
Invesco
Georgia
$155K +$8.73K +858 +6%
GCP
45
GSA Capital Partners
United Kingdom
$149K +$152K +14,900 New
GF
46
Gabelli Funds
New York
$140K – – –
DM
47
Deerfield Management
New York
$139K +$141K +13,893 New
VKH
48
Virtu KCG Holdings
New York
$122K +$124K +12,229 New
Morgan Stanley
49
Morgan Stanley
New York
$117K -$55.6K -5,461 -32%
State Street
50
State Street
Massachusetts
$117K -$47.2K -4,636 -28%
1
2
3

ELOS Hedge Fund Activity: Q3 2014 in Review

65 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2014, worth a combined $270M — down 3% from $278M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ELOS positions and 7 closed out — a net gain of 5 holders — while 12 added to existing stakes and 19 trimmed.

The largest buyer was Dalton, Greiner, Hartman, Maher & Co, opening a new position worth an estimated $8.04M. The largest seller was Baupost Group, cutting an estimated $10.2M.

  • 65 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2014, up from 61 in Q2 2014.
  • Funds reported $270M of Syneron Medical Ltd stock for Q3 2014, down 3% quarter-over-quarter.
  • 12 funds opened new Syneron Medical Ltd positions in Q3 2014 and 7 closed out, a net change of +5 holders.
  • The largest Syneron Medical Ltd buyer in Q3 2014 was Dalton, Greiner, Hartman, Maher & Co, an estimated $8.04M added.
  • The largest Syneron Medical Ltd seller in Q3 2014 was Baupost Group, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2014.